#SFHS2613356VSet Prices for Wegovy Pharmaceutical Products
AI-generated summary for informational purposes only. Not legal advice. See the original source for the authoritative text.
This notice sets the official prices for several Wegovy semaglutide injectable pen presentations sold by Novo Nordisk in France. The listed pre-tax manufacturer prices range from €127.06 to €169.13, with tax-inclusive public prices ranging from €146.91 to €195.10. The new prices apply from 15 June 2026. Pharmacies, wholesalers, healthcare payers, prescribers, and patients using Wegovy should use these prices for the listed presentations from that date.
AI-generated summary. May contain errors. Refer to official sources for legal decisions.
Key Changes
- Sets official prices for six Wegovy semaglutide injectable pen presentations in France
- Lists tax-exclusive manufacturer prices between €127.06 and €169.13
- Applies the new prices from 15 June 2026
Obligations
What this law requires
Apply the fixed official prices for WEGOVY 0.25 mg FlexTouch, CIP 34009 302 586 2 0: PFHT €127.06 and PPTTC €146.91, from 15 June 2026.
Apply the fixed official prices for WEGOVY 0.50 mg FlexTouch, CIP 34009 302 586 3 7: PFHT €127.06 and PPTTC €146.91, from 15 June 2026.
Apply the fixed official prices for WEGOVY 1 mg FlexTouch, CIP 34009 302 586 4 4: PFHT €127.06 and PPTTC €146.91, from 15 June 2026.
Apply the fixed official prices for WEGOVY 1.7 mg FlexTouch, CIP 34009 302 602 4 1: PFHT €146.58 and PPTTC €169.31, from 15 June 2026.
Apply the fixed official prices for WEGOVY 2.4 mg FlexTouch, CIP 34009 302 586 6 8: PFHT €169.13 and PPTTC €195.10, from 15 June 2026.